Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4

Silvia Cellone Trevelin; Can Martin Sag; Min Zhang; José Carlos Alves-Filho; Thiago Mattar Cunha; Célio Xavier Dos Santos; Greta Sawyer; Thomas Murray; Alison Brewer; Francisco Rafael Martins Laurindo; Andrea Protti; Lucia Rossetti Lopes; Aleksandar Ivetic; Fernando Queiroz Cunha; Ajay M. Shah

doi:10.1097/SHK.0000000000001706

Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4

Silvia Cellone Trevelin, Can Martin Sag, Min Zhang, José Carlos Alves-Filho, Thiago Mattar Cunha, Célio Xavier Dos Santos, Greta Sawyer, Thomas Murray, Alison Brewer, Francisco Rafael Martins Laurindo, Andrea Protti, Lucia Rossetti Lopes, Aleksandar Ivetic, Fernando Queiroz Cunha, Ajay M. Shah

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

ABSTRACT: Leukocyte Nox2 is recognized to have a fundamental microbicidal function in sepsis but the specific role of Nox2 in endothelial cells (EC) remains poorly elucidated. Here, we tested the hypothesis that endothelial Nox2 participates in the pathogenesis of systemic inflammation and hypotension induced by LPS. LPS was injected intravenously in mice with Tie2-targeted deficiency or transgenic overexpression of Nox2. Mice with Tie2-targeted Nox2 deficiency had increased circulating levels of TNF-α, enhanced numbers of neutrophils trapped in lungs, and aggravated hypotension after LPS injection, as compared to control LPS-injected animals. In contrast, Tie2-driven Nox2 overexpression attenuated inflammation and prevented the hypotension induced by LPS. Because Tie2-Cre targets both EC and myeloid cells we generated bone marrow chimeric mice with Nox2 deletion restricted to leukocytes or ECs. Mice deficient in Nox2 either in leukocytes or ECs had reduced LPS-induced neutrophil trapping in the lungs and lower plasma TNF-α levels as compared to control LPS-injected mice. However, the pronounced hypotensive response to LPS was present only in mice with EC-specific Nox2 deletion. Experiments in vitro with human vein or aortic endothelial cells (HUVEC and HAEC, respectively) treated with LPS revealed that EC Nox2 controls NF-κB activation and the transcription of toll-like receptor 4 (TLR4), which is the recognition receptor for LPS. In conclusion, these results suggest that endothelial Nox2 limits NF-κB activation and TLR4 expression, which in turn attenuates the severity of hypotension and systemic inflammation induced by LPS.

Original language	English
Pages (from-to)	268-277
Number of pages	10
Journal	Shock (Augusta, Ga.)
Volume	56
Issue number	2
DOIs	https://doi.org/10.1097/SHK.0000000000001706
Publication status	Published - 1 Aug 2021

Access to Document

10.1097/SHK.0000000000001706

Cite this

Trevelin, S. C., Sag, C. M., Zhang, M., Alves-Filho, J. C., Cunha, T. M., Santos, C. X. D., Sawyer, G., Murray, T., Brewer, A., Laurindo, F. R. M., Protti, A., Lopes, L. R., Ivetic, A., Cunha, F. Q., & Shah, A. M. (2021). Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4. Shock (Augusta, Ga.), 56(2), 268-277. https://doi.org/10.1097/SHK.0000000000001706

@article{3e2a6c787c474579aa6c39ca59552da4,

title = "Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4",

abstract = "ABSTRACT: Leukocyte Nox2 is recognized to have a fundamental microbicidal function in sepsis but the specific role of Nox2 in endothelial cells (EC) remains poorly elucidated. Here, we tested the hypothesis that endothelial Nox2 participates in the pathogenesis of systemic inflammation and hypotension induced by LPS. LPS was injected intravenously in mice with Tie2-targeted deficiency or transgenic overexpression of Nox2. Mice with Tie2-targeted Nox2 deficiency had increased circulating levels of TNF-α, enhanced numbers of neutrophils trapped in lungs, and aggravated hypotension after LPS injection, as compared to control LPS-injected animals. In contrast, Tie2-driven Nox2 overexpression attenuated inflammation and prevented the hypotension induced by LPS. Because Tie2-Cre targets both EC and myeloid cells we generated bone marrow chimeric mice with Nox2 deletion restricted to leukocytes or ECs. Mice deficient in Nox2 either in leukocytes or ECs had reduced LPS-induced neutrophil trapping in the lungs and lower plasma TNF-α levels as compared to control LPS-injected mice. However, the pronounced hypotensive response to LPS was present only in mice with EC-specific Nox2 deletion. Experiments in vitro with human vein or aortic endothelial cells (HUVEC and HAEC, respectively) treated with LPS revealed that EC Nox2 controls NF-κB activation and the transcription of toll-like receptor 4 (TLR4), which is the recognition receptor for LPS. In conclusion, these results suggest that endothelial Nox2 limits NF-κB activation and TLR4 expression, which in turn attenuates the severity of hypotension and systemic inflammation induced by LPS.",

author = "Trevelin, {Silvia Cellone} and Sag, {Can Martin} and Min Zhang and Alves-Filho, {Jos{\'e} Carlos} and Cunha, {Thiago Mattar} and Santos, {C{\'e}lio Xavier Dos} and Greta Sawyer and Thomas Murray and Alison Brewer and Laurindo, {Francisco Rafael Martins} and Andrea Protti and Lopes, {Lucia Rossetti} and Aleksandar Ivetic and Cunha, {Fernando Queiroz} and Shah, {Ajay M.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society. Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = aug,

day = "1",

doi = "10.1097/SHK.0000000000001706",

language = "English",

volume = "56",

pages = "268--277",

journal = "Shock (Augusta, Ga.)",

issn = "1540-0514",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "2",

}

Trevelin, SC , Sag, CM , Zhang, M, Alves-Filho, JC, Cunha, TM, Santos, CXD, Sawyer, G , Murray, T , Brewer, A, Laurindo, FRM, Protti, A, Lopes, LR, Ivetic, A, Cunha, FQ & Shah, AM 2021, 'Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4', Shock (Augusta, Ga.), vol. 56, no. 2, pp. 268-277. https://doi.org/10.1097/SHK.0000000000001706

TY - JOUR

T1 - Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4

AU - Trevelin, Silvia Cellone

AU - Sag, Can Martin

AU - Zhang, Min

AU - Alves-Filho, José Carlos

AU - Cunha, Thiago Mattar

AU - Santos, Célio Xavier Dos

AU - Sawyer, Greta

AU - Murray, Thomas

AU - Brewer, Alison

AU - Laurindo, Francisco Rafael Martins

AU - Protti, Andrea

AU - Lopes, Lucia Rossetti

AU - Ivetic, Aleksandar

AU - Cunha, Fernando Queiroz

AU - Shah, Ajay M.

N1 - Publisher Copyright: Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Shock Society. Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/8/1

Y1 - 2021/8/1

N2 - ABSTRACT: Leukocyte Nox2 is recognized to have a fundamental microbicidal function in sepsis but the specific role of Nox2 in endothelial cells (EC) remains poorly elucidated. Here, we tested the hypothesis that endothelial Nox2 participates in the pathogenesis of systemic inflammation and hypotension induced by LPS. LPS was injected intravenously in mice with Tie2-targeted deficiency or transgenic overexpression of Nox2. Mice with Tie2-targeted Nox2 deficiency had increased circulating levels of TNF-α, enhanced numbers of neutrophils trapped in lungs, and aggravated hypotension after LPS injection, as compared to control LPS-injected animals. In contrast, Tie2-driven Nox2 overexpression attenuated inflammation and prevented the hypotension induced by LPS. Because Tie2-Cre targets both EC and myeloid cells we generated bone marrow chimeric mice with Nox2 deletion restricted to leukocytes or ECs. Mice deficient in Nox2 either in leukocytes or ECs had reduced LPS-induced neutrophil trapping in the lungs and lower plasma TNF-α levels as compared to control LPS-injected mice. However, the pronounced hypotensive response to LPS was present only in mice with EC-specific Nox2 deletion. Experiments in vitro with human vein or aortic endothelial cells (HUVEC and HAEC, respectively) treated with LPS revealed that EC Nox2 controls NF-κB activation and the transcription of toll-like receptor 4 (TLR4), which is the recognition receptor for LPS. In conclusion, these results suggest that endothelial Nox2 limits NF-κB activation and TLR4 expression, which in turn attenuates the severity of hypotension and systemic inflammation induced by LPS.

AB - ABSTRACT: Leukocyte Nox2 is recognized to have a fundamental microbicidal function in sepsis but the specific role of Nox2 in endothelial cells (EC) remains poorly elucidated. Here, we tested the hypothesis that endothelial Nox2 participates in the pathogenesis of systemic inflammation and hypotension induced by LPS. LPS was injected intravenously in mice with Tie2-targeted deficiency or transgenic overexpression of Nox2. Mice with Tie2-targeted Nox2 deficiency had increased circulating levels of TNF-α, enhanced numbers of neutrophils trapped in lungs, and aggravated hypotension after LPS injection, as compared to control LPS-injected animals. In contrast, Tie2-driven Nox2 overexpression attenuated inflammation and prevented the hypotension induced by LPS. Because Tie2-Cre targets both EC and myeloid cells we generated bone marrow chimeric mice with Nox2 deletion restricted to leukocytes or ECs. Mice deficient in Nox2 either in leukocytes or ECs had reduced LPS-induced neutrophil trapping in the lungs and lower plasma TNF-α levels as compared to control LPS-injected mice. However, the pronounced hypotensive response to LPS was present only in mice with EC-specific Nox2 deletion. Experiments in vitro with human vein or aortic endothelial cells (HUVEC and HAEC, respectively) treated with LPS revealed that EC Nox2 controls NF-κB activation and the transcription of toll-like receptor 4 (TLR4), which is the recognition receptor for LPS. In conclusion, these results suggest that endothelial Nox2 limits NF-κB activation and TLR4 expression, which in turn attenuates the severity of hypotension and systemic inflammation induced by LPS.

UR - http://www.scopus.com/inward/record.url?scp=85111869362&partnerID=8YFLogxK

U2 - 10.1097/SHK.0000000000001706

DO - 10.1097/SHK.0000000000001706

M3 - Article

C2 - 34276040

AN - SCOPUS:85111869362

SN - 1540-0514

VL - 56

SP - 268

EP - 277

JO - Shock (Augusta, Ga.)

JF - Shock (Augusta, Ga.)

IS - 2

ER -

Endothelial Nox2 Limits Systemic Inflammation and Hypotension in Endotoxemia by Controlling Expression of Toll-Like Receptor 4

Abstract

Access to Document

Other files and links

Fingerprint

Cite this